Guolin Wang Selected Research

Inflammation (Inflammations)

1/2021	Hydrogen Gas Alleviates Sepsis-Induced Brain Injury by Improving Mitochondrial Biogenesis Through the Activation of PGC-α in Mice.
12/2020	Effect of dexmedetomidine on hemodynamic changes and inflammatory responses in patients undergoing off-pump coronary-artery bypass grafting.
8/2017	Intraperitoneal gardiquimod protects against hepatotoxicity through inhibition of oxidative stress and inflammation in mice with sepsis.
1/2017	Hydrogen Gas Protects Against Intestinal Injury in Wild Type But Not NRF2 Knockout Mice With Severe Sepsis by Regulating HO-1 and HMGB1 Release.
1/2016	PICK1 Regulates the Expression and Trafficking of AMPA Receptors in Remifentanil-Induced Hyperalgesia.
10/2015	H2 Treatment Attenuated Pain Behavior and Cytokine Release Through the HO-1/CO Pathway in a Rat Model of Neuropathic Pain.
7/2014	Hydrogen-rich saline controls remifentanil-induced hypernociception and NMDA receptor NR1 subunit membrane trafficking through GSK-3β in the DRG in rats.
11/2012	Protective effects of hydrogen-rich saline in a rat model of permanent focal cerebral ischemia via reducing oxidative stress and inflammatory cytokines.
5/2012	Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis.
11/2010	Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guolin Wang Research Topics

Disease

25	Hyperalgesia 01/2022 - 01/2013
24	Pain (Aches) 01/2022 - 09/2003
15	Sepsis (Septicemia) 01/2021 - 07/2010
10	Inflammation (Inflammations) 01/2021 - 11/2010
8	Postoperative Pain 01/2022 - 12/2006
6	Neuralgia (Stump Neuralgia) 01/2022 - 10/2015
6	Hypersensitivity (Allergy) 12/2021 - 07/2014
6	Brain Ischemia (Cerebral Ischemia) 10/2019 - 10/2011
5	Neuroinflammatory Diseases 01/2022 - 11/2014
5	Cognitive Dysfunction 08/2020 - 03/2014
5	Reperfusion Injury 02/2019 - 03/2011
4	Tibial Fractures (Fracture, Tibial) 01/2022 - 11/2020
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2019 - 10/2011
4	Ischemia 10/2019 - 03/2011
4	Neoplasms (Cancer) 11/2018 - 06/2015
3	Bone Fractures (Bone Fracture) 01/2022 - 11/2020
3	Acute Pain 01/2022 - 11/2020
3	Chronic Pain 01/2022 - 01/2016
3	Lung Injury 12/2021 - 05/2012
3	Brain Injuries (Brain Injury) 01/2021 - 11/2014
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 09/2015
3	Postoperative Cognitive Complications 10/2018 - 04/2016
3	Stroke (Strokes) 11/2014 - 10/2011
2	Malaria 01/2022 - 01/2022
2	Acute Lung Injury 12/2021 - 05/2012
2	Diabetes Complications 01/2019 - 09/2015
2	Carcinoma (Carcinomatosis) 11/2018 - 03/2016
2	Alzheimer Disease (Alzheimer's Disease) 10/2018 - 08/2016
2	Infarction (Infarctions) 11/2014 - 10/2011
2	Hyperoxia 12/2012 - 05/2012
1	Pulmonary Atelectasis 11/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

22	HydrogenIBA 12/2021 - 07/2010
15	Remifentanil (Ultiva)FDA Link 01/2022 - 01/2013
12	Proteins (Proteins, Gene)FDA Link 05/2021 - 05/2012
10	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2021 - 01/2013
10	Sevoflurane (Ultane)FDA LinkGeneric 02/2019 - 03/2014
8	Propofol (Diprivan)FDA LinkGeneric 01/2020 - 10/2011
6	AcidsIBA 01/2022 - 01/2013
6	AMPA Receptors (AMPA Receptor)IBA 01/2021 - 02/2015
6	salicylhydroxamic acid (SHAM)IBA 10/2019 - 06/2014
5	Analgesics (Analgesic Drugs)IBA 01/2022 - 09/2003
5	AntioxidantsIBA 10/2020 - 07/2010
5	Opioid Analgesics (Opioids)IBA 07/2019 - 01/2013
4	LipopolysaccharidesIBA 12/2021 - 05/2012
4	N-Methylaspartate (NMDA)IBA 01/2021 - 01/2016
4	Dexmedetomidine FDA Link 12/2020 - 01/2015
4	HMGB1 Protein (HMG1)IBA 01/2017 - 07/2010
4	hydrogen rich salineIBA 12/2015 - 05/2012
4	CytokinesIBA 10/2015 - 05/2012
3	ArtesunateIBA 01/2022 - 01/2022
3	Pharmaceutical PreparationsIBA 01/2022 - 07/2014
3	ChemokinesIBA 01/2022 - 05/2012
3	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2018
3	NAD (NADH)IBA 01/2020 - 09/2015
3	Morphine (MS Contin)FDA LinkGeneric 08/2019 - 09/2003
3	Messenger RNA (mRNA)IBA 10/2015 - 06/2014
3	EnzymesIBA 10/2015 - 07/2010
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2022 - 01/2016
2	Metabotropic Glutamate 5 ReceptorIBA 01/2022 - 01/2022
2	Purinergic Receptors (Receptors, Purine)IBA 12/2021 - 01/2021
2	1-naphthylacetylspermineIBA 01/2021 - 01/2020
2	IronIBA 01/2021 - 01/2021
2	Midazolam (Versed)FDA LinkGeneric 11/2018 - 12/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018 - 07/2010
2	Interleukin-6 (Interleukin 6)IBA 08/2017 - 05/2012
2	Alanine Transaminase (SGPT)IBA 11/2016 - 12/2012
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2015 - 01/2015
2	zinc protoporphyrinIBA 07/2015 - 06/2015
2	Heme Oxygenase-1IBA 07/2015 - 06/2015
2	Neuroprotective AgentsIBA 11/2014 - 11/2012
2	ZymosanIBA 01/2014 - 11/2010
2	Uric Acid (Urate)IBA 11/2013 - 03/2012
2	AMPA 2 glutamate receptor ionotropicIBA 01/2013 - 10/2011
2	Peroxidase (Myeloperoxidase)IBA 12/2012 - 05/2012
1	artemisinin (artemisinine)IBA 01/2022
1	Antimalarials (Antimalarial Agents)IBA 01/2022
1	AntigensIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Superoxides (Superoxide)IBA 01/2022
1	FluorineIBA 01/2022
1	pyridineIBA 01/2022
1	3,4-dihydroxyphenylglycolIBA 01/2022
1	Therapeutic UsesIBA 12/2021
1	N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphateIBA 12/2021
1	Dizocilpine Maleate (Dizocilpine)IBA 12/2021
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2021
1	Caspase 6IBA 01/2021
1	MetalsIBA 01/2021
1	Netrin-1IBA 01/2021

Therapy/Procedure

10	Therapeutics 01/2022 - 07/2010
9	Ligation 01/2021 - 12/2012
9	Punctures 01/2021 - 12/2012
6	Orthopedic Procedures 01/2022 - 03/2014
5	General Anesthesia 11/2022 - 01/2014
4	Anesthesia 04/2018 - 01/2015
3	Spinal Injections 01/2022 - 01/2016
2	Pain Management 01/2022 - 05/2019
2	Critical Care (Surgical Intensive Care) 12/2020 - 07/2010
2	Analgesia 10/2017 - 01/2015